Human IFN-γ ELISA antibody pair - 20-plate

SKU
CT740-20
Validated ELISA antibody pair with standard and conjugate; reagents available separately (1920 determinations).
Format
20-plate
Price
€ 1,055
Documentation
Data sheet
Manual
SDS
Reactivity
Human
Category
ELISA
Analyte
IFN-γ
Description
Our ELISA antibody pairs are extensively validated for high assay performance using the same reagents and materials included in U-CyTech ELISA kits. These antibody pairs are optimized to ensure reliable, sensitive, and reproducible results in a wide range of ELISA applications.
The ELISA antibody pairs are available in convenient 10- or 20-plate formats, providing 960 or 1920 determinations, respectively. Each set is supplied with either 5 or 10 vials of standards and 2 or 4 vials of Streptavidin-HRP conjugate, offering flexibility for different experimental needs and throughput requirements.
Designed for ease of use and consistent performance, these ELISA reagents support accurate quantification in immunoassays. Additional ELISA plates and reagents can be purchased separately, allowing customization of your ELISA workflow.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Gene ID
3458

References

Authors, et al. Title Journal Year Volume Pages
Annemieke Geluk Enhancing sensitivity of detection of immune responses to Mycobacterium leprae peptides in whole-blood assays Clin Vaccine Immunol 2010 17 993-1004
Varsha Sewgobind Characterization of rabbit antithymocyte globulins-induced CD25+ regulatory T cells from cells of patients with end-stage renal disease Transplantation 2010 89 655-66
Simone Joosten Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity PLoS Pathog 2010 6 e1000782
May Lin Cross-reactive immunity to Mycobacterium tuberculosis DosR regulon-encoded antigens in individuals infected with environmental, nontuberculous mycobacteria Infect Immun 2009 77 5071-9
Annemieke Geluk From genome-based in silico predictions to ex vivo verification of leprosy diagnosis Clin Vaccine Immunol 2009 16 352-9
Marjoleine Brouw Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus Immunology 2009 126 280-9
Paul Corstjens A user-friendly, highly sensitive assay to detect the IFN-gamma secretion by T cells Clin Biochem 2008 41 440-4
Annemieke Geluk Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection Clin Vaccine Immunol 2008 15 522-33
Thanyalak Tha-In Intravenous immunoglobulins suppress T-cell priming by modulating the bidirectional interaction between dendritic cells and natural killer cells Blood 2007 110 3253-62
Astrid van Beelen Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells Immunity 2007 27 660-9